Key result
Persistent AF is linked to ~319% greater odds of left atrial low-voltage zones.
Why the study?
Additional ablation targeting low-voltage zones reduces AF recurrence, but the pre-procedural predictors of these low-voltage zones remain elusive.
What are the pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation for atrial fibrillation?
Observational (n=359)
No
What are the pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation for atrial fibrillation?
Older age, female sex, dilated cardiomyopathy, hypertrophic cardiomyopathy, persistent AF, and larger left atrial volume independently predict the presence of low-voltage zones, which may help guide ablation strategies in AF patients.
Identifies pre-procedural predictors of low-voltage zones; hypothesis-generating for tailored ablation strategies pending prospective validation.
Pulmonary vein isolation has become a cornerstone treatment for catheter ablation of atrial fibrillation (AF). Recent reports show that additional ablation targeting low-voltage zones reduces AF recurrence. However, the pre-procedural predictors of low-voltage zones remain elusive. We retrospectively enrolled 359 patients (mean age 63.7 ± 10.8 years; 73 females; and 149 had persistent atrial fibrillation) who underwent catheter ablation for AF and left atrial (LA) voltage mapping during sinus rhythm or atrial pacing. Low-voltage zones were defined as area of > 5 cm2 with a bipolar electrogram amplitude of < 0.50 mV. Overall, 51 (14.2%) patients had low-voltage zones. Patients with low-voltage zones were older (67.9 ± 9.9 vs. 63.0 ± 10.8 years; P = 0.003), predominantly female (33.3% vs. 18.2%; P = 0.013), had higher prevalence of dilated cardiomyopathy (DCM) (11.8% vs. 1.6%; P = 0.002) and hypertrophic cardiomyopathy (HCM) (9.8% vs. 2.6%; P = 0.025), and had larger LA volumes (153.6 ± 46.4 vs. 117.7 ± 67.8 mL; P < 0.001) than those without low-voltage zones. Multivariate logistic regression analysis revealed that age (OR 1.060; 95% CI 1.022-1.101, P = 0.002), female sex (OR 2.978; 95% CI 1.340-6.615, P = 0.007), DCM (OR 8.341; 95% CI 1.381-50.372, P = 0.021), HCM (OR 5.044; 95% CI 1.314-19.363, P = 0.018), persistent AF (OR 4.188; 95% CI 1.928-9.100, P < 0.001), and larger LA volume (OR 3.215; 95% CI 1.378-7.502, P = 0.007) were independently associated with the presence of low-voltage zones. Patient age, female sex, DCM, HCM, persistent AF and larger LA volume may predict the presence of low-voltage zones and could be useful in selecting the appropriate ablation strategy for AF.
No takes yet. Share an insight, caveat, or question.
Ikoma et al. (2022) conducted an observational in Atrial fibrillation (n=359). Pre-procedural clinical factors (e.g., persistent AF) vs. Absence of risk factors was evaluated on Presence of low-voltage zones (LVZ) (OR 4.188, 95% CI 1.928-9.100, p=<0.001). Older age, female sex, dilated and hypertrophic cardiomyopathy, persistent atrial fibrillation (OR 4.188), and larger left atrial volume independently predicted left atrial low-voltage zones.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: